Abstract
A novel nucleoside analog, 8-chloro-7-deazaguanosine (8-Cl-7-dzGuo), was evaluated for anti-RNA virus activity in rodents in parallel with the related compound 7-deaza-7-thia-8-oxoguanosine (7-dzTOGuo). Half-daily intraperitoneal (i.p.) doses of each substance administered 24 and 18 h prior to i.p. virus challenge protected the majority of mice infected with banzi, encephalomyocarditis, San Angelo, and Semliki Forest viruses at doses of 25, 50 and 100 mg/kg/day. These compounds at 100 mg/kg/day also protected most suckling rats infected intranasally with rat coronavirus. However, no survival benefit was afforded to treated mice infected intranasally with vesicular stomatitis virus. 8-Cl-7-dzguo was orally active against Semliki Forest virus in mice at 200 and 400 mg/kg/day, whereas 7-dzTOGuo is reported to not be effective orally. In uninfected mice, the two compounds induced similar amounts of interferon following i.p. injections. Interferon was induced by oral treatments with 8-Cl-7-dzGuo but not with 7-dzTOGuo. Fifty percent acute lethal doses to uninfected mice treated i.p. in half-daily doses for one day with 7-deazaguanosine (7-dzGuo), 7-dzTOGuo, and 8-Cl-7-dzGuo were 400, 600 and > 1600 (no mortality at this dose) mg/kg/day, respectively. Daily, i.p. treatments for 14 days with these substances (100 mg/kg/day) showed 7-dzGuo as 100% lethal and the other two substances at not toxic. By virtue of reduced toxicity and oral bioavailability, 8-Cl-7-dzGuo appears to have the greatest clinical potential as an interferon-inducing antiviral agent.
Keywords: Antiviral, 7-Deazaguanosine, Alphavirus, Bunyavirus, Flavivirus, Picornavirus, Coronavirus, Interferon inducer
References
- Kunder S.C., Kelly K.M., Morahan P.S. Biological response modifier-mediated resistance to herpesvirus infections requires induction of αβ interferon. Antiviral Res. 1993;21:129–139. doi: 10.1016/0166-3542(93)90049-o. [DOI] [PubMed] [Google Scholar]
- Michael M.A., Cottam H.B., Smee D.F., Robins R.K., Kini G.D. Alkylpurines as immunepotentiating agents. Synthesis and antiviral activity of certain alkylguaninesJ. Med. Chem. 1993;36:3431–3436. doi: 10.1021/jm00074a025. [DOI] [PubMed] [Google Scholar]
- Morahan P.S., Pinto A.J., Stewart D., Murasko D.M., Brinton M.A. Varying role of αβ interferon in the antiviral efficacy of synthetic immuno-modulators against Semliki Forest virus infection. Antiviral Res. 1991;15:241–254. doi: 10.1016/0166-3542(91)90070-8. [DOI] [PubMed] [Google Scholar]
- Nagahara K., Anderson J.D., Kini G.D., Dalley N.K., Larson S.B., Smee D.F., Jin A., Sharma B.S., Jolley W.B., Robins R.K., Cottam H.B. Thiazolo[4,5-d]pyrimidine nucleosides. The synthesis of certain 3-β-d-ribofuranosylthiazolo[4,5-d]pyrimidines as potential immunotherapeutic agentsJ. Med. Chem. 1990;33:407–415. doi: 10.1021/jm00163a064. [DOI] [PubMed] [Google Scholar]
- Ramasamy K., Imamura N., Robins R.K., Revankar G.R. A facile and improved synthesis of tubercidin and certain pyrrolo[2,3-d]pyrimidine nucleosides by the stereospecific sodium salt glycosylation procedure. J. Heterocycl. Chem. 1988;25:1893–1898. [Google Scholar]
- Sarzotti M., Coppenhaver D.H., Singh I.P., Poast J., Baron S. The in vivo antiviral effect of CL246,738 is mediated by the independent induction of interferon-α and interferon-β. J. Interferon Res. 1989;9:265–274. doi: 10.1089/jir.1989.9.265. [DOI] [PubMed] [Google Scholar]
- Smee D.F., Alaghamandan H.A., Cottam H.B., Sharma B.S., Jolley W.B., Robins R.K. Broad-spectrum in vivo antiviral activity of 7-thia-8-oxoguanosine, a novel immunopotentiating agent. Antimicrob. Agents Chemother. 1989;33:1487–1492. doi: 10.1128/aac.33.9.1487. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smee D.F., Alaghamandan H.A., Cottam H.B., Jolley W.B., Robins R.K. Antiviral activity of the novel immune modulator 7-thia-8-oxoguanosine. J. Biol. Response Modif. 1990;9:24–32. [PubMed] [Google Scholar]
- Smee D.F., Alaghamandan H.A., Bartlett M.L., Robins R.K. Intranasal treatment of picornavirus and coronavirus respiratory infections in rodents using 7-thia-8-oxoguanosine. Antiviral Chem. Chemother. 1990;1:47–52. [Google Scholar]
- Smee D.F., Alaghamandan H.A., Jin A., Sharma B.S., Jolley W.B. Roles of interferon and natural killer cells in the antiviral activity of 7-thia-8-oxoguanosine against Semliki Forest virus infections in mice. Antiviral Res. 1990;13:91–102. doi: 10.1016/0166-3542(90)90025-3. [DOI] [PubMed] [Google Scholar]
- Smee D.F., Alaghamandan H.A., Gilbert J., Burger R.A., Jin A., Sharma B.S., Ramasamy K., Revankar G.R., Cottam H.B., Jolley W.B., Robins R.K. Immunoenhancing properties and antiviral activity of 7-deazaguanosine in mice. Antimicrob. Agents Chemother. 1991;35:152–157. doi: 10.1128/aac.35.1.152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smee D.F., Huffman J.H., Gessaman A.C., Huggins J.W., Sidwell R.W. Prophylactic and therapeutic activities of 7-thia-8-oxoguanosine against Punta Toro virus infections in mice. Antiviral Res. 1991;15:229–239. doi: 10.1016/0166-3542(91)90069-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smee D.F., Cottam H.B., Sharma B.S., Kini G.D., Revankar G.R., Ojo-Amaize E., Sidwell R.W., Jolley W.B., Robins R.K. Antiviral and immunoenhancing properties of 7-thia-8-oxoguanosine and related guanosine analogues. Can. J. Infect. Dis. 1992;3(Suppl B):41B–48B. [Google Scholar]
- Stringfellow D.A., Kern E.R., Kelsey D.K., Glasgow L.A. Suppressed response to interferon induction in mice infected with encephalomyocarditis virus, Semliki Forest virus, influenza A2 virus, Herpesvirus hominis type 2, or murnie cytomegalovirus. J. Infect. Dis. 1977;135:540–551. doi: 10.1093/infdis/135.4.540. [DOI] [PubMed] [Google Scholar]